IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $949,000 | -94.5% | 28,200 | -92.3% | 0.00% | -88.2% |
| Q1 2020 | $17,320,000 | +41.2% | 366,320 | +60.7% | 0.02% | -15.0% |
| Q4 2019 | $12,270,000 | -66.7% | 228,001 | -66.0% | 0.02% | -67.2% |
| Q3 2019 | $36,801,000 | +236.8% | 669,687 | +245.9% | 0.06% | +221.1% |
| Q2 2019 | $10,926,000 | +243.8% | 193,600 | +209.9% | 0.02% | +216.7% |
| Q2 2017 | $3,178,000 | +26.6% | 62,464 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $2,511,000 | -11.4% | 62,464 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $2,833,000 | +3.3% | 62,464 | -16.6% | 0.01% | 0.0% |
| Q3 2016 | $2,743,000 | -18.0% | 74,864 | -47.9% | 0.01% | -16.7% |
| Q2 2016 | $3,344,000 | +10.3% | 143,564 | +91.8% | 0.01% | 0.0% |
| Q1 2016 | $3,032,000 | -99.9% | 74,864 | +88.0% | 0.01% | 0.0% |
| Q4 2015 | $2,465,495,000 | – | 39,811 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |